IRX Therapeutics, Inc.
| Article | Date | Source |
|---|
| Isis Pharmaceuticals, Inc. Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia | May 04, 2012 | BioSpace - Breaking News |
| Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia | May 04, 2012 | Pharma News - PR Newswire |
| Webcast Alert: Isis Pharmaceuticals, Inc. Holds Webcast to Discuss Clinical Development Plans for ISIS-APOCIIIRx | April 19, 2012 | BioSpace - Breaking News |
| VentiRx Pharmaceuticals Publishes Preclinical Data of Novel TLR8 Agonist, VTX-2337, Supporting Its Potential as an Immunotherapeutic Approach in Cancer | January 23, 2012 | Biotech News - PR Newswire |
| Isis Reports Positive Phase 1 Data Demonstrating ISIS-FXIRx Reduces Factor XI Activity Without Bleeding | December 12, 2011 | Clinical Trials - PR Newswire |
| Isis Reports Positive Phase 1 Data Demonstrating ISIS-APOCIIIRx Produces Significant Reductions in apoC-III Protein Levels and Triglycerides | December 06, 2011 | Pharma News - PR Newswire |
| Scott Announces IRX Therapeutics, to Bring 280 Jobs to St. Pete in 5 Years, at Public Cost of $1.2 Million | October 24, 2011 | Biotechnology - Moreover |
| <b>Scott</b> Announces IRX Therapeutics, to Bring 280 Jobs to St. Pete in 5 Years, at Public Cost of $1.2 Million | October 24, 2011 | BioSpace - Breaking News |
| IRX Therapeutics comes home to Tampa Bay area | October 20, 2011 | Health News - BizJournals.com |
| Ion Torrent Racing to Change Healthcare, VentiRx to Close SD Office, RF Surgical Raises $12M, and More San Diego Life Sciences News | September 15, 2011 | Xconomy Life Sciences |
| VentiRx Pharmaceuticals, Inc. Concentrates on Cancer Development to Conserve Cash | September 14, 2011 | BioSpace |
| VentiRx Concentrates Its Bet on Cancer, and Seattle | September 13, 2011 | Xconomy Life Sciences |
| Positron Moves into New PosiRx Manufacturing Facility | August 18, 2011 | Pharma News - Business Wire |
| Omnicell's OmniRx Automated Medication Dispensing System Receives 2011 Best in KLAS Award | June 16, 2011 | Pharma News - PR Newswire |
| VentiRx Pharmaceuticals Presents Results from Phase 1 Clinical Trial of VTX-2337, a Novel TLR8 Agonist, in Patients with Advanced Solid Tumors at American Society of Clinical Oncology Annual Meeting | June 06, 2011 | Pharma News - Business Wire |
| CertiRx goes into medications to show how to spot counterfeit drugs | June 03, 2011 | Pharmaceutical - Moreover |
| / CORRECTION - Emerging Markets Foster New Growth -- Equity Research on Angel Biotechnology and Valirx PLC | June 03, 2011 | Biotechnology - Moreover |
| Emerging Markets Foster New Growth -- Equity Research on Angel Biotechnology and Valirx PLC | June 02, 2011 | Biotechnology - Moreover |
| Positron’s PosiRx System Readies for Commercial Deployment | March 28, 2011 | Pharma News - Business Wire |
| VentiRx Pharmaceuticals Presents Positive Clinical and Pre-Clinical Data at American Academy of Allergy Asthma & Immunology Annual Meeting | March 21, 2011 | Pharma News - PR Newswire |
| IRX Therapeutics Enters Research Collaboration
 | March 02, 2011 | Contract Pharma |
| IRX Therapeutics Announces New Research Collaboration | March 01, 2011 | Pharma News - Business Wire |
| Isis Pharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of ISIS-FXIRx to Treat Clotting Disorders | February 02, 2011 | BioSpace - Breaking News |
| Isis Initiates Phase 1 Clinical Trial of ISIS-FXIRx to Treat Clotting Disorders | February 02, 2011 | Pharma News - PR Newswire |
| Isis Pharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of ISIS-APOCIIIRx to Treat Hypertriglyceridemia | December 21, 2010 | BioSpace - Breaking News |
| Isis Initiates Phase 1 Clinical Trial of ISIS-APOCIIIRx to Treat Hypertriglyceridemia | December 21, 2010 | Pharma News - PR Newswire |
| VentiRx Pharmaceuticals, Inc. Reports Positive Clinical Data for VTX-1463 in Allergic Rhinitis | October 07, 2010 | BioSpace - Breaking News |
| VentiRx Pharmaceuticals Reports Positive Clinical Data for VTX-1463 in Allergic Rhinitis | October 07, 2010 | Biotech News - PR Newswire |
| Immunovaccine and IRX Therapeutics sign research collaboration for cancer immunotherapies | October 05, 2010 | Biotechnology - Moreover |
| Immunovaccine and IRX Therapeutics Collaborate on Cancer Immunotherapies | October 05, 2010 | Marketwire - Pharma and Biotech |
| VentiRx Cancer Drug Passes Early Trial | October 04, 2010 | Xconomy Life Sciences |
| VentiRx Pharmaceuticals, Inc.' Novel TLR8 Agonist, VTX-2337, Successfully Completes Phase 1 Clinical Trial in Oncology | October 04, 2010 | BioSpace - Breaking News |
| VentiRx Pharmaceuticals' Novel TLR8 Agonist, VTX-2337, Successfully Completes Phase 1 Clinical Trial in Oncology | October 04, 2010 | Clinical Trials - PR Newswire |
| FierceBiotech Names VentiRx Pharmaceuticals as One of the 'Fierce 15' Biotech Companies of 2010 | September 15, 2010 | Biotech News - PR Newswire |
| IRX Therapeutics Raises $8 Million to Develop Therapeutic Vaccines for Cancer and Viral Diseases | June 16, 2010 | BioSpace - Breaking News |
| IRX Therapeutics Announces Cancer Vaccine Collaboration with Japan’s National Cancer Research Center | April 29, 2010 | Pharma News - Business Wire |
| IRX Therapeutics Appoints Chief Scientific Officer | January 15, 2010 | BioSpace - Breaking News |
| IRX Therapeutics Appoints Neil L. Berinstein Chief Scientific Officer | January 15, 2010 | Pharma News - Business Wire |
| VentiRx Pharmaceuticals Raises More Funds, Genzyme Declares a Truce, Adventrx Charts Comeback, & More San Diego Life Sciences News | January 14, 2010 | Xconomy Life Sciences |
| VentiRx Nabs $25M, Gilead Deepens Seattle Roots, Sage Strikes Deal With Pfizer & More Seattle-Area Life Sciences News | January 14, 2010 | Xconomy Life Sciences |
| VentiRx Pharmaceuticals Raises $25 Million in Series A Extension Financing | January 12, 2010 | Biotech News - PR Newswire |
| VentiRx Pharmaceuticals, Inc. Raises $25 Million in Series A Extension Financing | January 12, 2010 | BioSpace |
| VentiRx Pockets $25M to Fund Clinical Development of TLR8 Candidates | January 12, 2010 | GEN News Highlights |
| VentiRx Nabs $25M for Cancer, Allergy Drugs | January 12, 2010 | Xconomy Life Sciences |
| VentiRx scores $25M in VC | January 12, 2010 | FierceBiotech |
